Alcon Total Assets 2019-2022 | ALC

Alcon total assets from 2019 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Alcon total assets for the quarter ending September 30, 2022 were $27.796B, a 0.02% decline year-over-year.
  • Alcon total assets for 2021 were $27.999B, a 1.45% increase from 2020.
  • Alcon total assets for 2020 were $27.6B, a 0.2% decline from 2019.
  • Alcon total assets for 2019 were $27.655B, a 2.19% increase from 2018.
Alcon Annual Total Assets
(Millions of US $)
2021 $27,999
2020 $27,600
2019 $27,655
2018 $27,062
Alcon Quarterly Total Assets
(Millions of US $)
2022-09-30 $27,796
2022-06-30 $27,727
2022-03-31 $27,790
2021-12-31 $27,999
2021-09-30 $27,802
2021-06-30 $27,750
2021-03-31 $27,368
2020-12-31 $27,600
2020-09-30 $27,414
2020-06-30 $27,481
2020-03-31 $27,199
2019-12-31 $27,655
2019-09-30 $27,633
2019-06-30 $27,774
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $33.321B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Edwards Lifesciences (EW) United States $46.932B 32.30
STERIS (STE) Ireland $18.019B 22.42
Teleflex (TFX) United States $10.587B 17.18
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Globus Medical (GMED) United States $7.103B 36.11
Integer Holdings (ITGR) United States $2.367B 19.00
Glaukos (GKOS) United States $2.263B 0.00
Nevro (NVRO) United States $1.556B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00